Health reform prods partnership of St. Vincent, OrthoIndy

Back to TopCommentsE-mailPrintBookmark and Share

St. Vincent Health and OrthoIndy are the latest hospital and physician groups to run into each others' arms in response to the reform winds coming out of Washington, D.C.

The two Indianapolis-based organizations announced Friday they will create a management company to handle physician work at St. Vincent's hospitals in Indianapolis. St. Vincent also acquired a minority stake in OrthoIndy's orthopaedic hospital, located a few miles west of St. Vincent's flagship facility on West 86th Street.

Both organizations say they want to expand their offerings of orthopaedic care around the state, particularly to rural areas in which orthopaedic physicians are scarce.

But they are also positioning themselves for a future that they expect will include lower reimbursement payments from federal programs, as well as incentives for hospitals and doctors to work more closely.

“Clearly, when we did this transaction, we had an eye on health car reform,” said John Martin, CEO of OrthoIndy, a group of more than 70 physicians who specialize in bone, joint and spine therapy.

All doctors face a 21-percent cut to Medicare reimbursement next year unless Congress steps in to change it, which it has done in the past. And Martin said that, with Congress spending nearly $1 trillion to expand health insurance coverage, he’s not banking on reimbursement from federal programs reversing their recent trends of falling or staying flat.

Stagnant reimbursement hasn’t prevented OrthoIndy from steadily increasing its profit margins at its Indiana Orthopaedic Hospital. It opened in March 2005, and generated a gain of $2.6 million that year, or 4.5 percent of gross revenue.

But, in 2008, the hospital posted a gain of nearly $29 million, or 18.2 percent of gross revenue, according to information from American Hospital Directory Inc.

It’s no surprise why St. Vincent was interesting in owning a piece of that hospital. Margins at its Indianapolis hospital were one-quarter as large last year, at 4.5 percent. Both hospitals’ results included gains from investment income.

OrthoIndy and St. Vincent officials declined to say how large a stake St. Vincent bought, or how much St. Vincent paid for the stake.

When OrthoIndy opened its hospital, St. Vincent officials criticized the physicians for skimming off the most profitable patients.

But relationships have warmed since then, with OrthoIndy physicians conducting surgeries at St. Vincent hospitals and participating in its Sports Performance program. OrthoIndy also provides orthopaedic emergency department services at St. Vincent Indianapolis Hospital.

Further integration can only help improve quality and reduce costs more, Martin said, which will be key to thriving if health reform leads to lower reimbursement. Health reform bills in Congress call for incentives to encourage hospitals and doctors to form partnerships to better coordinate care for patients.

“We’ve developed a pretty efficient clinic model,” he said of the Indiana Orthopaedic Hospital. “We’d like to leverage some of that in other places.”

Other local hospitals are already deep into similar efforts. Community Health Network has hired or signed integration agreements with more than 250 physicians this year.

Clarian Health is forming a joint venture with the Indiana University School of Medicine to combine their physicians under the Indiana Clinic banner. So far, about 375 doctors have signed up. Clarian is also trying to sign physicians to integration agreements under a program called Clarian Quality Partners.

And St. Vincent said it’s not done with the OrthoIndy deal.

“We will continue our approach to programmatic growth through physician alignment and trusted partnerships with health providers across the state,” said Kevin Speer, St. Vincent’s chief strategy officer, in a prepared statement. St. Vincent is a subsidiary of St. Louis-based Ascension Health, the nation’s largest operator of Catholic hospitals.

Even though OrthoIndy is formally partnering with St. Vincent, Martin stressed that OrthoIndy would continue to serve patients in the city’s other hospitals, including Methodist, Community South, St. Francis and Hendricks Regional. OrthoIndy will also start seeing patients at Hancock Regional in Greenfield next month and at Major Hospital in Shelbyville in January.

“We continue to support all the other hospitals in town,” he said.


  • OrthoIndy
    St. Vincent and OrthoIndy partnership
  • good deal
    This is a good deal for both AND for patients as in addition to getting some hi dollar ortho cases from Ortho Indy side, St Vincent can in turn provide medicine coverage for the orthopedic inpatients that just didn't seem to have enough internal medicine preparedness at times when a patient in for ortho work got ill from ileus, C dif or other ailment while there. The "well" patients did fine but hard to get follow ups on labs or other information for the patients who needed medicine diagnosis and treatment while there and afterward follow up as well. A good partnership and good solution for preventing future problems, never mind the moneymaking side of things. Good doctors there and they can spend more time practicing and doing their clinical research and less time on management which they might not be as interested in.

Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

  2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

  3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

  4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

  5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?